ATE226070T1 - Taxol enthaltende pharmazeutische injektionslösung - Google Patents

Taxol enthaltende pharmazeutische injektionslösung

Info

Publication number
ATE226070T1
ATE226070T1 AT97921986T AT97921986T ATE226070T1 AT E226070 T1 ATE226070 T1 AT E226070T1 AT 97921986 T AT97921986 T AT 97921986T AT 97921986 T AT97921986 T AT 97921986T AT E226070 T1 ATE226070 T1 AT E226070T1
Authority
AT
Austria
Prior art keywords
taxol
tromethamine
containing taxol
pharmaceutical solution
injection containing
Prior art date
Application number
AT97921986T
Other languages
English (en)
Inventor
Man Woo Han
Nam Doo Hong
Jae Kuk Yoo
Original Assignee
Man Woo Han
Nam Doo Hong
Jae Kuk Yoo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Man Woo Han, Nam Doo Hong, Jae Kuk Yoo filed Critical Man Woo Han
Application granted granted Critical
Publication of ATE226070T1 publication Critical patent/ATE226070T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT97921986T 1997-05-30 1997-05-30 Taxol enthaltende pharmazeutische injektionslösung ATE226070T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1997/000623 WO1998053810A1 (en) 1997-05-30 1997-05-30 Pharmaceutical injection solution containing taxol

Publications (1)

Publication Number Publication Date
ATE226070T1 true ATE226070T1 (de) 2002-11-15

Family

ID=11004572

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97921986T ATE226070T1 (de) 1997-05-30 1997-05-30 Taxol enthaltende pharmazeutische injektionslösung

Country Status (4)

Country Link
EP (1) EP0998279B1 (de)
AT (1) ATE226070T1 (de)
DE (1) DE69716485T2 (de)
WO (1) WO1998053810A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004536026A (ja) * 2000-11-28 2004-12-02 トランスフォーム ファーマシューティカルズ,インコーポレーティッド. パクリタキセル、その誘導体、および薬剤として許容される塩を含む医薬品製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157049A (en) * 1988-03-07 1992-10-20 The United States Of America As Represented By The Department Of Health & Human Services Method of treating cancers sensitive to treatment with water soluble derivatives of taxol
FR2678833B1 (fr) * 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
KR100371062B1 (ko) * 1992-11-27 2003-04-21 에프.에이치.포울딩 앤드 컴퍼니 리미티드 안정성이향상된주사가능한택솔조성물및이를제형화하는방법
FR2698543B1 (fr) * 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa Nouvelles compositions à base de taxoides.

Also Published As

Publication number Publication date
DE69716485T2 (de) 2003-04-10
WO1998053810A1 (en) 1998-12-03
DE69716485D1 (de) 2002-11-21
EP0998279A1 (de) 2000-05-10
EP0998279B1 (de) 2002-10-16

Similar Documents

Publication Publication Date Title
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
IT1270594B (it) Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
DE69331409D1 (de) Oral 1alpha-hydroxyprevitamin d
EA200200431A1 (ru) Фармацевтические композиции, обеспечивающие повышенные концентрации лекарства
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
PT916347E (pt) Solucoes farmaceuticas injectaveis contendo paracetamol e combinacoes de paracetamol com outras substancias activas
KR960700061A (ko) 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence)
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
KR970025615A (ko) 암 전이 억제제
KR910000703A (ko) 테트라졸 자극성 아미노산 수용체의 길항물질
SE9002500L (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
ID22763A (id) Komposisi penstabil tibolon
BRPI0407438A (pt) Sistema terapêutico compreendendo amoxicilina e ácido clavulânico
DE69520292D1 (de) Pharmazeutische zubereitung zur direktverpressung
SE9301877D0 (sv) In situ gel for therapeutic use
KR910007523A (ko) 과콜레스테린혈증, 과지방혈증 및 혈전색전증 질병 치료용 토코트리엔올
DE69716485D1 (de) Taxol enthaltende pharmazeutische injektionslösung
KR910009267A (ko) 우울증의 치료방법
KR970073583A (ko) 탁속을 함유한 주사용 약제 조성물
KR960003717A (ko) 항암제에 의해 유발되는 말초신경병의 예방에 유용한 의약의 제조를 위한 엘리프로딜 및 그 거울상이성질체의 이용
RU94032792A (ru) Применение 5нтiа - антагонистов для прекращения использования табака
KR910002434A (ko) 레티노이드의 용도
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
KR920019356A (ko) 약제학적 조성물 및 그 제조방법
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0998279

Country of ref document: EP